No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antirheumatic Agents / administration & dosage
-
Antirheumatic Agents / adverse effects
-
Arthritis, Rheumatoid* / diagnosis
-
Arthritis, Rheumatoid* / drug therapy
-
Arthritis, Rheumatoid* / physiopathology
-
Drug Eruptions / etiology
-
Drug Monitoring
-
Etanercept
-
Female
-
Hepatitis, Autoimmune* / diagnosis
-
Hepatitis, Autoimmune* / etiology
-
Hepatitis, Autoimmune* / physiopathology
-
Hepatitis, Autoimmune* / therapy
-
Humans
-
Immunoglobulin G / administration & dosage
-
Immunoglobulin G / adverse effects*
-
Interleukin 1 Receptor Antagonist Protein / administration & dosage*
-
Liver / pathology
-
Liver Function Tests / methods
-
Receptors, Tumor Necrosis Factor / administration & dosage
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunoglobulin G
-
Interleukin 1 Receptor Antagonist Protein
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Adalimumab
-
Etanercept